Skip to main content
PMC home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1998 Dec;106(Suppl 6):1585–1587. doi: 10.1289/ehp.98106s61585

Roles of lead-binding proteins in mediating lead bioavailability.

B A Fowler 1
PMCID: PMC1533439  PMID: 9860918

Abstract

The intracellular bioavailability of lead (Pb) at low dosage levels in major target organs such as the kidney and brain appears to be largely determined by complexation with a group of low molecular weight proteins. These proteins are rich in aspartic and glutamic dicarboxyl amino acids. The proteins are chemically similar but not identical across all species examined to date and the brain protein appears to be different from that found in the kidney. These proteins possess dissociation constant values for Pb on the order of 10(-8) M and appear to normally bind zinc. In rats, these proteins attenuate the Pb inhibition of the heme pathway enzyme delta-aminolevulinic acid dehydratase by a mechanism involving both Pb chelation and zinc donation to this highly Pb-sensitive zinc-dependent enzyme. Other studies in rats have shown that the kidney protein facilitates the intranuclear movement of Pb in vitro followed by chromatin binding, suggesting that this protein may be involved in alterations of the pathognomonic Pb intranuclear inclusion bodies in renal gene expression associated with the mitogenic effects of Pb in the kidney.

Full text

PDF
1586

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. DuVal G., Fowler B. A. Preliminary purification and characterization studies of a low molecular weight, high affinity cytosolic lead-binding protein in rat brain. Biochem Biophys Res Commun. 1989 Feb 28;159(1):177–184. doi: 10.1016/0006-291x(89)92420-0. [DOI] [PubMed] [Google Scholar]
  2. Fowler B. A., DuVal G. Effects of lead on the kidney: roles of high-affinity lead-binding proteins. Environ Health Perspect. 1991 Feb;91:77–80. doi: 10.1289/ehp.919177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fowler B. A., Kahng M. W., Smith D. R., Conner E. A., Laughlin N. K. Implications of lead binding proteins for risk assessment of lead exposure. J Expo Anal Environ Epidemiol. 1993 Oct-Dec;3(4):441–448. [PubMed] [Google Scholar]
  4. Fowler B. A., Kahng M. W., Smith D. R. Role of lead-binding proteins in renal cancer. Environ Health Perspect. 1994 Sep;102 (Suppl 3):115–116. doi: 10.1289/ehp.94102s3115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Goering P. L., Fowler B. A. Mechanism of renal lead-binding protein reversal of delta-aminolevulinic acid dehydratase inhibition by lead. J Pharmacol Exp Ther. 1985 Aug;234(2):365–371. [PubMed] [Google Scholar]
  6. Goering P. L., Fowler B. A. Regulation of lead inhibition of delta-aminolevulinic acid dehydratase by a low molecular weight, high affinity renal lead-binding protein. J Pharmacol Exp Ther. 1984 Oct;231(1):66–71. [PubMed] [Google Scholar]
  7. Goering P. L., Mistry P., Fowler B. A. A low molecular weight lead-binding protein in brain attenuates lead inhibition of delta-aminolevulinic acid dehydratase: comparison with a renal lead-binding protein. J Pharmacol Exp Ther. 1986 Apr;237(1):220–225. [PubMed] [Google Scholar]
  8. Hitzfeld B., Planas-Bohne F., Taylor D. The effect of lead on protein and DNA metabolism of normal and lead-adapted rat kidney cells in culture. Biol Trace Elem Res. 1989 Jul-Sep;21:87–95. doi: 10.1007/BF02917240. [DOI] [PubMed] [Google Scholar]
  9. Lolin Y., O'Gorman P. An intra-erythrocytic low molecular weight lead-binding protein in acute and chronic lead exposure and its possible protective role in lead toxicity. Ann Clin Biochem. 1988 Nov;25(Pt 6):688–697. doi: 10.1177/000456328802500616. [DOI] [PubMed] [Google Scholar]
  10. Mahaffey K. R., Capar S. G., Gladen B. C., Fowler B. A. Concurrent exposure to lead, cadmium, and arsenic. Effects on toxicity and tissue metal concentrations in the rat. J Lab Clin Med. 1981 Oct;98(4):463–481. [PubMed] [Google Scholar]
  11. Mills J. S., Johnson J. D. Metal ions as allosteric regulators of calmodulin. J Biol Chem. 1985 Dec 5;260(28):15100–15105. [PubMed] [Google Scholar]
  12. Mistry P., Lucier G. W., Fowler B. A. High-affinity lead binding proteins in rat kidney cytosol mediate cell-free nuclear translocation of lead. J Pharmacol Exp Ther. 1985 Feb;232(2):462–469. [PubMed] [Google Scholar]
  13. Mistry P., Mastri C., Fowler B. A. Influence of metal ions on renal cytosolic lead-binding proteins and nuclear uptake of lead in the kidney. Biochem Pharmacol. 1986 Feb 15;35(4):711–713. doi: 10.1016/0006-2952(86)90371-0. [DOI] [PubMed] [Google Scholar]
  14. Moore J. F., Goyer R. A., Wilson M. Lead-induced inclusion bodies. Solubility, amino acid content, and relationship to residual acidic nuclear proteins. Lab Invest. 1973 Nov;29(5):488–494. [PubMed] [Google Scholar]
  15. Oskarsson A., Fowler B. A. Effects of lead on the heme biosynthetic pathway in rat kidney. Exp Mol Pathol. 1985 Dec;43(3):409–417. doi: 10.1016/0014-4800(85)90077-2. [DOI] [PubMed] [Google Scholar]
  16. Oskarsson A., Squibb K. S., Fowler B. A. Intracellular binding of lead in the kidney: the partial isolation and characterization of postmitochondrial lead binding components. Biochem Biophys Res Commun. 1982 Jan 15;104(1):290–298. doi: 10.1016/0006-291x(82)91973-8. [DOI] [PubMed] [Google Scholar]
  17. Quintanilla-Vega B., Smith D. R., Kahng M. W., Hernández J. M., Albores A., Fowler B. A. Lead-binding proteins in brain tissue of environmentally lead-exposed humans. Chem Biol Interact. 1995 Dec 22;98(3):193–209. doi: 10.1016/0009-2797(95)03646-6. [DOI] [PubMed] [Google Scholar]
  18. Raghavan S. R., Gonick H. C. Isolation of low-molecular-weight lead-binding protein from human erythrocytes. Proc Soc Exp Biol Med. 1977 Jun;155(2):164–167. doi: 10.3181/00379727-155-39766. [DOI] [PubMed] [Google Scholar]
  19. Shelton K. R., Egle P. M. The proteins of lead-induced intranuclear inclusion bodies. J Biol Chem. 1982 Oct 10;257(19):11802–11807. [PubMed] [Google Scholar]
  20. Shelton K. R., Todd J. M., Egle P. M. The induction of stress-related proteins by lead. J Biol Chem. 1986 Feb 5;261(4):1935–1940. [PubMed] [Google Scholar]
  21. Smith D. R., Kahng M. W., Quintanilla-Vega B., Fowler B. A. High-affinity renal lead-binding proteins in environmentally-exposed humans. Chem Biol Interact. 1998 Aug 14;115(1):39–52. doi: 10.1016/s0009-2797(98)00060-x. [DOI] [PubMed] [Google Scholar]
  22. Suzuki Y., Chao S. H., Zysk J. R., Cheung W. Y. Stimulation of calmodulin by cadmium ion. Arch Toxicol. 1985 Aug;57(3):205–211. doi: 10.1007/BF00290889. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES